Poster Abstracts • OFID 2018:5 (Suppl 1) • S261 mildly/severely or extremely severe ill patients; lower IL-5 levels were seen in LTD (Figure 3 ). VL correlated with TNF-α (P < 0.001) and IL-10 (P < 0.001) levels. After logistic regression analysis, socioeconomic, pregnancy and infant variables showed no association with bad outcomes; only frequent consumption of fruits and vegetables during pregnancy conferred protection (aOR 0.03; P < 0.001).
Background. Emergency medicine physicians are among the top five specialties prescribing antibiotics. New accreditation standards for outpatient antimicrobial stewardship are now in effect, thus evaluation of antibiotic prescribing practices in the emergency department (ED) is needed. Upper respiratory infections (URIs) have been shown to be a common culprit for inappropriate antibiotic use and are among the leading primary diagnoses seen at ED visits. We aimed to assess the management of URIs in the adult and pediatric EDs by diagnosis and provider type, in order to target interventions to improve use.
Methods. In this retrospective, single-center cohort study, we included adult and pediatric patients seen in the ED and discharged home from September 2015 through August 2017. Patients with one of eight ICD-10 primary diagnosis codes associated with URIs were included (Figure 1 ). The primary outcome was to evaluate prescriber compliance with guidelines for the treatment of URIs among our adult and pediatric ED departments. Secondary outcomes included assessment of patient outcomes (14-day hospital and clinic revisit rates) between the compliant and noncompliant cohorts, and a comparison of prescribing practices among prescriber types.
Results. A total of 1,646 adult ED encounters and 2,589 pediatric ED encounters were included, with overall 84.0% and 94.4% compliance, respectively. Among URIs, compliance rates were low for bronchitis in adult patients (68.3%) and tonsillitis in both the adult (44.3%) and pediatric patients (57.6%). No difference in outcomes, including 14-day hospital and clinic revisit rates, were observed between groups for both the adult (12.7% vs. 14.8%, P = 0.37) and pediatric (18.8% vs. 17.9%, P = 0.91) cohorts. Higher rates of noncompliance were seen in adult and pediatric physicians (37.5% and 10.3%) compared with corresponding advanced practice providers (14.9% and 9.6%) and residents (12.1% and 4.5%).
Conclusion. The ED provides care for a large number of patients with URIs and should be a focus for antimicrobial stewardship. To be most effective, future stewardship interventions in the ED should target physician groups, and bronchitis in adults and tonsillitis in all patients. Background. Respiratory syncytial virus (RSV) produces annual epidemics that vary in the timing of season onset, peak, and duration by season and by geographic region. Recent analyses by the US Centers for Disease Control at the national level have demonstrated that polymerase chain reaction (PCR) testing has largely replaced rapid antigen testing as the predominant test type and that the traditional 10% positivity threshold for defining an RSV season based on antigen testing should not be applied to PCR testing, for which the comparable threshold for real-time surveillance was 3%. The aim of this study was to validate and model implementation of the antigen (10%) and PCR (3%) positivity thresholds at regional, state, and local levels in a large national dataset of RSV testing results from US hospitals.
Methods. RSV test results were obtained from 599 laboratories that participated from 2011 to 2016 in RSVAlert ® , a national RSV surveillance program. For laboratories that provided consistent weekly data (≥10 tests for ≥30 weeks of a season), regional test numbers and positivity were summarized weekly by test type within each season. Season onset and offset were calculated for the 10 US Department of Health and Human Services (HHS) regions and 10 large states plus Hawaii based on (1) antigen only for all seasons, (2) PCR only for all seasons, and (3) the predominant test type used in a specific geography in a season (either antigen or PCR).
Results. An average of 543,340 RSV tests was reported each season. At the regional and state levels, there were fewer outlier estimates of RSV season length when the predominant regional test type was used to define the season (Figures 1 and 2 ). Exceptions were few and occurred with antigen testing data.
